CollPlant, Stratasys Explore 3D-Printed Breast Implants
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
A principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.